Skip to main content

Month: March 2020

SpareBank 1 SMN : SpareBank 1 SMN to lower interest rates on home mortgages

SpareBank 1 SMN is to lower its interest rates on home mortgages by up to 0.35 percentage points for new and existing borrowers. The bank is at the same time making it simpler to apply for a mortgage payment holiday.The new lowest mortgage rate will be 2.50 per cent, on Green Mortgages.“SpareBank 1 SMN will keep its cool, and will go to great lengths to enable customers to get through the corona crisis. We are now lowering our interest rates, making mortgages cheaper. We are also making it simpler for mortgage holders to apply for a mortgage payment holiday. Many people are already affected by lay-offs, and the indications are, unfortunately, that there are far more to come. A break from mortgage repayments will make managing day-to-day finances less demanding,” says executive director Nelly Maske at SpareBank 1 SMN.“The corona pandemic...

Continue reading

SpareBank 1 SMN : SpareBank 1 SMN setter ned renta på boliglån

SpareBank 1 SMN setter ned renta på boliglån med inntil 0,35 prosentpoeng for nye og eksisterende kunder. Samtidig blir det enklere å søke om avdragsfrihet.Ny laveste rente blir 2,50 prosent for Grønt boliglån.– SpareBank 1 SMN skal ha is i magen, og vi vil strekke oss langt for at våre kunder kommer seg gjennom koronakrisen. Nå setter vi ned renta og gjør boliglånet billigere. I tillegg gjør vi det enklere for de som har boliglån å søke om avdragsfrihet. Mange er allerede rammet av permitteringer på jobb, og mye tyder på at det dessverre kommer til å bli langt flere. Med avdragsfrihet blir det mindre krevende å få hverdagsøkonomien til å gå rundt, sier konserndirektør Nelly Maske i SpareBank 1 SMN.– Koronapandemien har utløst stor usikkerhet i markedet og gjort det dyrere å hente inn penger som vi igjen låner ut til våre...

Continue reading

LEXINGTON REALTY TRUST ANNOUNCES QUARTERLY COMMON SHARE DIVIDEND

NEW YORK, March 16, 2020 (GLOBE NEWSWIRE) — Lexington Realty Trust (NYSE:LXP) (“Lexington”), a real estate investment trust (REIT) focused on single-tenant industrial real estate investments, today announced that it declared a regular common share/unit dividend/distribution for the quarter ending March 31, 2020 of $0.105 per common share/unit payable on or about April 15, 2020 to common shareholders/unitholders of record as of March 31, 2020. Lexington also declared a cash dividend of $0.8125 per share of Series C Cumulative Convertible Preferred Stock for the quarter ending March 31, 2020, which is payable on or about May 15, 2020, to shareholders of record as of April 30, 2020.ABOUT LEXINGTON REALTY TRUSTLexington Realty Trust (NYSE: LXP) is a publicly traded real estate investment trust (REIT) focused on single-tenant industrial...

Continue reading

Investeringsforeningen Sydinvest, anmoder om ophør af suspension i afdeling.

March 16, 2020 07:34 ET | Source: SydinvestDa vi atter har mulighed for at stille priser på de europæiske markeder, samt obligationsmarkedet, anmodes om ophør af suspension af nedenstående afdeling:         (Selskabsmeddelelse 25/2020)ISIN Cur Ins. Name Long Cur Orderbook Code Cur Orderbook IdDK0015298384 Sydinvest Danmark A DKK SYIADKK 3827Med venlig hilsen Syd Fund Management A/S Tlf. 74 37 33 00

Continue reading

CloudMD to Offer Free-Trial Telemedicine Solutions to Healthcare Professionals Across North America to Help Manage Coronavirus Pandemic

VANCOUVER, British Columbia, March 16, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (CSE: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a Company focused on revolutionizing the delivery of healthcare, is pleased to announce it is immediately offering a free trial of its proprietary telemedicine solutions to North American healthcare professionals to help tackle the Coronavirus epidemic.The CDC and President Trump have recently announced that telemedicine is a vital part of fighting the current pandemic. On Friday, President Trump said his administration will waive certain federal rules to make it easier for more doctors to provide care remotely using video chats and other services. In addition, a recently announced coronavirus funding bill includes a provision that may help some Medicare beneficiaries...

Continue reading

ASCOT RESOURCES REPORTS 2019 ANNUAL RESULTS

VANCOUVER, British Columbia, March 16, 2020 (GLOBE NEWSWIRE) — Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) announces the Company’s audited consolidated financial results for the year ended December 31, 2019. For details of the audited consolidated financial statements, Management’s Discussion and Analysis, and Annual Information Form for the year ended December 31, 2019, please see the Company’s filings on SEDAR www.sedar.com.Derek White, President and CEO, commented, “Ascot had another busy year in 2019, beginning with the acquisition of the neighbouring Red Mountain project to create a leading high-grade gold development and exploration company in northwestern British Columbia’s Golden Triangle.I would like to take this opportunity to thank the hard-working team of people working...

Continue reading

Aleafia Health Secures Niagara Facility Cultivation Licence

TORONTO, March 16, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) wholly owned subsidiary, Aleafia Farms Inc., has secured a Health Canada Cultivation Licence (the “Licence”) for the Company’s Niagara Production Facility (the “Niagara Facility”), located in Grimsby, Ont. “This is an important and long-awaited breakthrough for Aleafia Health. We can now fully leverage our supply chain across three completed, licensed production facilities,” said Aleafia Health CEO Geoffrey Benic. “The Niagara Facility provides both near term, stable inventory for our health and wellness sales channels, and the inputs needed for the 2020 outdoor cultivation season.”The Facility features a highly advanced, automated, moving container bench system, which allows for a perpetual, year-round harvest....

Continue reading

NexTech AR To Acquire Work-At-Home Remote Virtual Events Webcasting Software Company

NEW YORK and TORONTO, March 16, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), the leader in augmented reality for eCommerce and AR learning applications, is pleased to announce that it has signed a binding LOI to acquire remote video training, live streaming software company Jolokia; whose customers include, Merck, Toyota CBS, Polycom and others.  The Jolokia platform generated $1mill USD in SaaS revenue for 2019.The transaction will be an all stock purchase with an initial payment upon closing of 1 million shares in restricted stock priced at $1 USD ($1.38 CAD) with a 12 month earn out if certain revenue milestones are hit of an additional $4mill in restricted stock. The company is currently conducting its due diligence with an expectation of a closing in the next few.With corporate...

Continue reading

Marinus Pharmaceuticals Provides Business Reports Update and 2019 Financial Results

RADNOR, Pa., March 16, 2020 (GLOBE NEWSWIRE) — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today provided a business update on its clinical development activities and reported its financial results for the year ended December 31, 2019.Key 2020 Planned Milestones:Initiate a pivotal Phase 3 clinical trial in patients with status epilepticus (SE) – mid-2020Initiate a Phase 2 clinical trial in patients with tuberous sclerosis complex (TSC) – Q2 2020Report top-line data from a global, pivotal Phase 3 clinical trial in children with CDKL5 deficiency disorder (CDD) – Q3 2020“We have started 2020 in a strong position, with recent accomplishments in the clinic that support our strategy to develop ganaxolone in mechanistically...

Continue reading

OpGen Provides Update on Curetis Now Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

– Rapid real-time PCR test allows testing for SARS-CoV2 in only a few hours– Test kit to be made available via Curetis’ European sales channels– Synergies with Curetis Unyvero HPN panel for pneumonia testing for bacterial co-infections in Covid-19 patients GAITHERSBURG, Md., March 16, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN) reported an update on the business of Curetis GmbH (“Curetis”), the other party to the planned business combination with OpGen. Today, Curetis announced that it started offering a CE-IVD certified real-time PCR test kit for SARS-CoV2 (also known as 2019-nCov), the causal pathogen of Corona Virus Disease 2019 (Covid-19). The test kit was developed and is manufactured by Curetis’ strategic partner BGI (Shenzhen, China) and was cleared by Chinese authorities in January 2020. In compliance...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.